ADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH KINASE INHIBITORS IN THE TREATMENT OF CANCER REVEAL SPECIFIC RISK BASED ON THE KINASE INHIBITOR - A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
Kwan J, Shen M, Mankbadi M, Wang P, Zaman S, Lee S, Jiang M, Tao W, Wei W, Akhlaghi N. ADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH KINASE INHIBITORS IN THE TREATMENT OF CANCER REVEAL SPECIFIC RISK BASED ON THE KINASE INHIBITOR - A SINGLE-CENTER RETROSPECTIVE COHORT STUDY. Journal Of The American College Of Cardiology 2022, 79: 1924. DOI: 10.1016/s0735-1097(22)02915-1.Peer-Reviewed Original ResearchSingle-center retrospective cohort studyKinase inhibitorsRetrospective cohort studyCohort studyAdverse CardiovascularCancer revealsInhibitorsCardiovascularADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS - A SINGLE CENTER RETROSPECTIVE COHORT STUDY
Kwan J, Akhlaghi N, Jiang M, Shen M, Im Y, Mankbadi M, Wang P, Zaman S, Lee S, Tao W, Wei W, Ma S. ADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS - A SINGLE CENTER RETROSPECTIVE COHORT STUDY. Journal Of The American College Of Cardiology 2022, 79: 1909. DOI: 10.1016/s0735-1097(22)02900-x.Peer-Reviewed Original ResearchSingle-center retrospective cohort studyCenter retrospective cohort studyImmune checkpoint inhibitorsRetrospective cohort studyCheckpoint inhibitorsCohort studyAdverse CardiovascularCardiovascular